Skip to main content
Premium Trial:

Request an Annual Quote

UK Insurance Group Extends Ban on Requiring Genetic Test Information

NEW YORK (GenomeWeb News) – A UK insurance industry group has decided to extend a rule through the year 2014 that keeps insurance customers from having to disclose genetic information from predictive tests.
 
The Association of British Insurers agreed on June 13 to extend a moratorium that was initiated in 2001 on insurance companies requiring results from customers.
 
The extension on the moratorium “means people can insure themselves and their families, even if they have had an adverse result from a predictive genetic test,” ABI Director General Stephen Haddrill said in a statement. He said it “has proved effective since its introduction” and that it “works well for consumers.”
 
The agreement to extend the moratorium through 2014 came after a scheduled review of the policy, and the next review will take place in 2011.
 
The moratorium covers policies worth up to £500,000 ($987,000) for life insurance and £300,000 for critical illness insurance.
 
Above these levels, the group said, its member insurers have agreed not to use predictive genetic tests unless the test has been approved by the government.
 
According to ABI, the only genetic test approved so far by the Genetics and Insurance Committee is for Huntington’s Disease and is for life insurance policies valued over £500,000.
 

The Scan

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.

Study Explores Animated Digital Message Approach to Communicate Genetic Test Results to Family Members

In the Journal of Genetic Counseling, the approach showed promise in participants presented with a hypothetical scenario related to a familial hereditary breast and ovarian cancer syndrome diagnosis.

Computational Tool Predicts Mammalian Messenger RNA Degradation Rates

A tool called Saluki, trained with mouse and human messenger RNA data, appears to improve mRNA half-life predictions by taking RNA and genetic features into account, a Genome Biology paper reports.

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.